Updated COVID-19 vaccine approved by FDA coming soon

by Matt Sheehan
OSF Healthcare

Photo provided
Dr. Doug Kasper
PEORIA - The fall virus season is upon us, and the U.S. Food & Drug Administration just approved one of the newest tools to protect Americans from severe illness.

The updated COVID-19 vaccine is expected to be available at pharmacies around the country in the coming weeks.

The mRNA vaccine is not a booster, says Doug Kasper, MD, an infectious disease specialist with OSF HealthCare. He says it’s recommended for a much broader portion of the population.

"The vaccine is now recommended for everybody 6 months and older as a one-time, once-a-year vaccine," Dr. Kasper says. “The vaccine has been updated. For people who are at really high risk, those 65 and older or with respiratory conditions, they may get a second shot. This would be in a six-month interval in the springtime.”

Does the vaccine prevent me from getting COVID-19?
The quick answer? No, much like you find with the annual influenza vaccine.

"The vaccine seeks to protect severe outcomes associated with COVID-19. It doesn't protect you from getting COVID, it tries to decrease the severity of how sick you would get," Dr. Kasper says.

While there has been an uptick in COVID-19 cases recently, Dr. Kasper says there has not been an increase in COVID hospitalizations. He attributes this to robust natural immunity in the population and adding this COVID-19 vaccine is just another way to protect yourself from severe illness.

FDA’s “What to Know” sheet
The 2024-2025 formula has been updated to protect against the Omicron variant KP.2.

  • Unvaccinated individuals 6 months through 4 years of age are eligible to receive three doses of the updated, authorized Pfizer-BioNTech COVID-19 vaccine or two doses of the updated, authorized Moderna COVID-19 vaccine.
  • Individuals 6 months through 4 years of age who have previously been vaccinated against COVID-19 are eligible to receive one or two doses of the updated, authorized Moderna or Pfizer-BioNTech COVID-19 vaccines (timing and number of doses to administer depends on the previous COVID-19 vaccine received).
  • Individuals 5 years through 11 years of age regardless of previous vaccination are eligible to receive a single dose of the updated, authorized Moderna or Pfizer-BioNTech COVID-19 vaccines; if previously vaccinated, the dose is administered at least two months after the last dose of any COVID-19 vaccine.
  • Individuals 12 years of age and older are eligible to receive a single dose of the updated, approved Comirnaty (manufactured by Pfizer BioNTech) or the updated, approved Spikevax (manufactured by Moderna); if previously vaccinated, the dose is administered at least two months since the last dose of any COVID-19 vaccine.
  • Additional doses are authorized for certain immunocompromised individuals ages 6 months through 11 years of age as described in the Moderna COVID-19 vaccine and Pfizer-BioNTech COVID-19 vaccine fact sheets.
Commercial retailers are the way to go
As the vaccines from Pfizer and Moderna become available, the Centers for Disease Control & Prevention (CDC) will publish a pharmacy lookup website at https://www.vaccines.gov/en/vaccines.gov to help people find the nearest vaccine locations.

Dr. Kasper says the best bet at getting a vaccine appointment for COVID-19 or influenza, is through pharmacies at local commercial retailers like Target, Walgreens, CVS or Walmart.

Free COVID-19 home tests are coming back
“The U.S. government will make the at-home COVID testing available for free again this year. You can request up to four home tests that will be delivered to your address for free,” Dr. Kasper says. That gives people another option for testing if they think they're developing signs of COVID even after receiving a vaccine, which can be another way to avoid wait lines at urgent cares, ERs or primary care clinics, and to keep themselves isolated until symptoms have resolved.”

The U.S. Department of Health & Human Services reports that COVIDTests.gov will be the website to order from once the website is active.

Status of the Novavax vaccine
A third manufacturer, Novavax, makes a protein-based vaccine similar to influenza vaccines. While it hasn’t been approved by the FDA, Dr. Kasper suspects it will be soon.

"It likely will be approved, and Novavax has been a prior manufacturer of COVID-19 vaccines. That is a third option that will be coming that isn't mRNA based for people to consider if they had an adverse reaction with Pfizer or Moderna in the past,” Dr. Kasper says.

Can I get the COVID-19 and flu vaccine at the same time?
"There's no issue with timing on getting the COVID and influenza vaccines. The RSV vaccine is recommended to be given separate," Dr. Kasper says. “Most of that has to do with the fact they weren't studied together, there's not an adverse issue with it. For the population, COVID and influenza are recommended across almost all age groups. RSV is for our older population, so we recommend spacing that out by a week or two.”

For all vaccine questions, Dr. Kasper recommends speaking with your primary care team to review your options.


Read our latest health and medical news

Open Season: Area prep football teams set to hit the turf tonight

St. Joseph - Coy Taylor returns to the gridiron tonight for the Spartans. During his junior year, Taylor hauled in 95 passes for 1342 receiving yards and averaged 122 yards per game. Look for the senior wide receiver to make big plays tonight in St. Joseph-Ogden's season opener on the road at Monticello. Kickoff is set for 7 pm.
Photo: Sentinel/Clark Brooks



TODAY'S SPORTS LINE UP

OAKWOOD VS MOMENCE
7:00 PM Central
STREAM LIVE
UNITY @ PRAIRIE CENTRAL
7:00 PM Central
STREAM LIVE
URBANA @ ST. TERESA
6:55 PM Central
STREAM LIVE
SJO Soccer VS HOOPESTON AREA
4:30 PM Central
STREAM LIVE
SJO JV Soccer VS HOOPESTON AREA
6:00 PM Central
STREAM LIVE
ST. JOSEPH-OGDEN @ MONTICELLO
6:30 PM Central
STREAM LIVE

Commentary |
Teaching about race is good, actually; states need to quit banning it

by Ian Wright
OtherWords.org

In this back to school season, millions of American students are returning to classrooms where the wrong course, lesson, or textbook can lead to deep trouble. Why? Because for the last several years, conservative activists and lawmakers have been waging a crusade against “critical race theory,” or CRT.

Critical race theory is an academic concept acknowledging that racism isn’t simply the result of individual prejudice but is also embedded in our institutions through laws, regulations, and rules.

As school districts have emphasized, it’s a higher education concept rarely taught in K-12 schools. But cynical activists have used CRT as a catch-all term to target a broad range of diversity, equity, and inclusion initiatives — and seemingly any discussion about race and racism in the classroom.

Since January 2021, 44 states have “introduced bills or taken other steps that would restrict teaching critical race theory or limit how teachers can discuss racism and sexism,” according to Education Weekly. And as of this writing, UCLA has identified 807 anti-CRT “bills, resolutions, executive orders, opinion letters, statements, and other measures” since September 2020.

Critics claim — falsely — that CRT teaches that all white people are oppressors, while Black people are simply oppressed victims. Many opponents claim it teaches white students to “hate their own race,” or to feel guilty about events that happened before they were born.

In reality, CRT gives students of every race the tools to understand how our institutions treat people of different races unequally — and how we can make those systems fairer. That’s learning students of every race would be better off with.

But instead, this barrage of draconian legislation is having a chilling effect on speech in the classroom.

In 2022, Florida passed the “Stop W.O.K.E. Act,” which prohibits teaching that could lead to a student feeling “discomfort” because of their race, sex, or nationality. But the law’s vague language makes it difficult for educators to determine what they can or cannot teach, ultimately restricting classroom instruction. In my home state of Texas, SB3 similarly restricts these classroom discussions.

Running afoul of these laws can get teachers and school administrators in trouble. As a result of this hostile environment, the RAND Corporation found that two-thirds of K-12 school teachers have decided “to limit instruction about political and social issues in the classroom.”

Notably, this self-censorship extends beyond states with such policies: 55 percent of teachers without state or local restrictions on CRT have still decided to limit classroom discussions of race and history.

As a student, I find this distressing.

My high school history classes gave me a much richer understanding of race in our history, especially the discussions we had at the height of the Black Lives Matter protests. And in college, I’ve gotten to learn about racial inequalities in everything from housing and real estate to health care, politics, education, and immigration policy.

As a person of color, I can’t imagine where I’d be without this understanding. Neither white students nor students of color will benefit from laws designed to censor their understanding of history, critical thinking, and open dialogue in the classroom.

The fight against CRT is a fight against the principles of education that encourage us to question, learn, and grow. Rather than shielding students from uncomfortable truths, which they can certainly handle, we should seek to equip them with the knowledge to navigate the world, think critically about our history and institutions, and push for a more inclusive country.


Ian Wright

Ian Wright is a Henry A. Wallace Fellow at the Institute for Policy Studies and a student at Rice University from Dallas, Texas. This op-ed was distributed by OtherWords.org.



More Sentinel Stories



Photo Galleries


2025 Illinois Marathon Photo Gallery
A couple of runners found themselves in the wrong race at this year's Illinois Marathon. Over 60 photos from the race that you should see.

Photos: Sentinel/Clark Brooks